Advisors Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Sell |
12,205
-2,076
| -15% | -$65K | 0.01% | 1000 |
|
|
2025
Q1 | $479K | Buy |
14,281
+1,233
| +9% | +$41.4K | 0.01% | 938 |
|
|
2024
Q4 | $511K | Sell |
13,048
-544
| -4% | -$21.3K | 0.01% | 923 |
|
|
2024
Q3 | $535K | Buy |
13,592
+493
| +4% | +$19.4K | 0.01% | 912 |
|
|
2024
Q2 | $511K | Sell |
13,099
-618
| -5% | -$24.1K | 0.01% | 894 |
|
|
2024
Q1 | $591K | Buy |
13,717
+3,301
| +32% | +$142K | 0.01% | 865 |
|
|
2023
Q4 | $480K | Buy |
10,416
+228
| +2% | +$10.5K | 0.01% | 901 |
|
|
2023
Q3 | $348K | Buy |
10,188
+2,096
| +26% | +$71.6K | 0.01% | 994 |
|
|
2023
Q2 | $312K | Sell |
8,092
-300
| -4% | -$11.6K | 0.01% | 1040 |
|
|
2023
Q1 | $300K | Buy |
8,392
+546
| +7% | +$19.5K | 0.01% | 1040 |
|
|
2022
Q4 | $309K | Buy |
7,846
+3,725
| +90% | +$147K | 0.01% | 1049 |
|
|
2022
Q3 | $149K | Sell |
4,121
-927
| -18% | -$33.5K | ﹤0.01% | 1193 |
|
|
2022
Q2 | $154K | Buy |
5,048
+2,900
| +135% | +$88.5K | ﹤0.01% | 1210 |
|
|
2022
Q1 | $66K | Buy |
+2,148
| New | +$66K | ﹤0.01% | 1387 |
|